{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T17:27:40Z","timestamp":1786728460092,"version":"build-2736575974"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.4103\/jcrt.jcrt_258_17","type":"journal-article","created":{"date-parts":[[2018,3,7]],"date-time":"2018-03-07T00:50:57Z","timestamp":1520383857000},"page":"159-162","source":"Crossref","is-referenced-by-count":9,"title":["Apatinib for advanced nonsmall-cell lung cancer"],"prefix":"10.4103","volume":"14","author":[{"given":"Chengxi","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-31-20230619","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3322\/caac.21338","article-title":"Cancer statistics in China, 2015","volume":"66","author":"Chen","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"R2-31-20230619","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1002\/cncr.29603","article-title":"Increased lung cancer mortality rates in the Chinese population from 1973-1975 to 2004-2005: An adverse health effect from exposure to smoking","volume":"121","author":"Zhi","year":"2015","journal-title":"Cancer"},{"key":"R3-31-20230619","doi-asserted-by":"crossref","first-page":"4258s","DOI":"10.1158\/1078-0432.CCR-040023","article-title":"Anti-vascular endothelial growth factor monoclonals in non-small cell lung cancer","volume":"10","author":"Sandler","year":"2004","journal-title":"Clin Cancer Res"},{"key":"R4-31-20230619","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1634\/theoncologist.2015-0221","article-title":"U.S. Food and drug administration approval summary: Ramucirumab for the treatment of metastatic non-small cell lung cancer following disease progression on or after platinum-based chemotherapy","volume":"20","author":"Larkins","year":"2015","journal-title":"Oncologist"},{"key":"R5-31-20230619","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ctrv.2012.05.003","article-title":"Targeted agents in the third-\/fourth-line treatment of patients with advanced (stage III\/IV) non-small cell lung cancer (NSCLC)","volume":"39","author":"Langer","year":"2013","journal-title":"Cancer Treat Rev"},{"key":"R6-31-20230619","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1200\/JCO.2015.63.5995","article-title":"Randomized, double-blind, placebo-controlled phase III trial of apatinib in patients with chemotherapy-refractory advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction","volume":"34","author":"Li","year":"2016","journal-title":"J Clin Oncol"},{"key":"R7-31-20230619","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.1158\/1078-0432.CCR-09-2797","article-title":"Vascular endothelial growth factor receptors VEGFR-2 and VEGFR-3 are localized primarily to the vasculature in human primary solid cancers","volume":"16","author":"Smith","year":"2010","journal-title":"Clin Cancer Res"},{"key":"R8-31-20230619","doi-asserted-by":"crossref","first-page":"7548","DOI":"10.1200\/jco.2012.30.15_suppl.7548","article-title":"A phase II, multicenter, placebo-controlled trial of apatinib in patients with advanced nonsquamous non-small cell lung cancer (NSCLC) after two previous treatment regimens","volume":"30","author":"Zhang","year":"2012","journal-title":"J Clin Oncol"},{"key":"R9-31-20230619","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1200\/JCO.2013.48.8585","article-title":"Apatinib for chemotherapy-refractory advanced metastatic gastric cancer: results from a randomized, placebo-controlled, parallel-arm, phase II trial","volume":"31","author":"Li","year":"2013","journal-title":"J Clin Oncol"},{"key":"R10-31-20230619","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1186\/1471-2407-14-820","article-title":"Multicenter phase II study of apatinib in non-triple-negative metastatic breast cancer","volume":"14","author":"Hu","year":"2014","journal-title":"BMC Cancer"},{"key":"R12-31-20230619","first-page":"2495","article-title":"New response evaluation criteria in solid tumors: Revised RECIST guideline (version 1.1)","volume":"36","author":"Watanabe","year":"2009","journal-title":"Gan To Kagaku Ryoho"},{"key":"R14-31-20230619","doi-asserted-by":"crossref","first-page":"5018","DOI":"10.1158\/1078-0432.CCR-06-1520","article-title":"Vascular endothelial growth factor signaling pathways: Therapeutic perspective","volume":"12","author":"Kowanetz","year":"2006","journal-title":"Clin Cancer Res"},{"key":"R15-31-20230619","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0140-6736(14)60845-X","article-title":"Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): A multicentre, double-blind, randomised phase 3 trial","volume":"384","author":"Garon","year":"2014","journal-title":"Lancet"},{"key":"R16-31-20230619","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(13)61719-5","article-title":"Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): An international, randomised, multicentre, placebo-controlled, phase 3 trial","volume":"383","author":"Fuchs","year":"2014","journal-title":"Lancet"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01363817-201814010-00031","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T16:27:18Z","timestamp":1786724838000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01363817-201814010-00031"}},"subtitle":["A retrospective case series analysis"],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_258_17","relation":{},"ISSN":["0973-1482"],"issn-type":[{"value":"0973-1482","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]}}}